Market Watch column provides a thorough analysis of stock market fluctuations and expert ratings.

Alnylam Pharmaceuticals Trading Volume Drops 51% to $189 Million, Ranks 490th in Market Activity

Market BriefFriday, May 2, 2025 7:45 pm ET

1min read

On May 2, 2025, alnylam pharmaceuticals (ALNY) saw a trading volume of $189 million, a 51.41% decrease from the previous day, ranking 490th in the day's stock market activity. The stock price increased by 1.67%.

Alnylam Pharmaceuticals reported a 28% year-over-year growth in global net product revenues for the first quarter of 2025, reaching $469 million. This growth was driven by strong performances from AMVUTTRA and ONPATTRO, which generated $310 million and $49 million in revenues, respectively, marking a 36% increase compared to the same period last year.

During the first quarter of 2025, Alnylam Pharmaceuticals reported an adjusted loss of $0.01 per share, which was significantly narrower than the estimated loss of $0.56 per share. This positive financial performance was highlighted during the company's earnings call, where key executives, including Yvonne Greenstreet, the Chief Executive Officer, and Jeff Poulton, the Chief Financial Officer, provided updates on the company's commercial progress, pipeline updates, and clinical developments.

Disclaimer: the above is a summary showing certain market information. AInvest is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from a third party source. Communications displaying market prices, data and other information available in this post are meant for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.